Philips Healthcare showcased at RSNA 2008 a hybrid SPECT/CT that incorporates a flat-panel x-ray system in place of a standard multislice CT. The FDA-cleared scanner, BrightView XCT, which debuted at the Society of Nuclear Medicine meeting in New Orleans, is built around the BrightView SPECT that Philips released commercially last year.
Philips Healthcare showcased at RSNA 2008 a hybrid SPECT/CT that incorporates a flat-panel x-ray system in place of a standard multislice CT. The FDA-cleared scanner, BrightView XCT, which debuted at the Society of Nuclear Medicine meeting in New Orleans, is built around the BrightView SPECT that Philips released commercially last year.
The novel combination is attuned specifically to the needs of specialists in nuclear medicine. The flat panel provides localization and attenuation correction at a lower cost than CT and with less technological complexity, so the system doesn't require special training for technologists, according to the company.
A side benefit is a two-thirds reduction in patient x-ray dose compared with MSCT. The XCT design is compact enough to allow siting in the same 12 x 15-foot room as the SPECT camera alone.
The system is scheduled to begin shipping next year at a price point somewhere between the company's $700,000 six-slice Precedence SPECT/CT and the $350,000 BrightView SPECT gamma camera. Beta testing is expected to begin in Q1 2009.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.